NM_001085382.2:c.1550C>T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001085382.2(PSAPL1):c.1550C>T(p.Ala517Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000789 in 1,420,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001085382.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAPL1 | ENST00000319098.7 | c.1550C>T | p.Ala517Val | missense_variant | Exon 1 of 1 | 6 | NM_001085382.2 | ENSP00000317445.4 | ||
SORCS2 | ENST00000507866.6 | c.548+36975G>A | intron_variant | Intron 2 of 26 | 1 | NM_020777.3 | ENSP00000422185.2 | |||
SORCS2 | ENST00000511199.1 | n.163+36975G>A | intron_variant | Intron 2 of 5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152244Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000140 AC: 10AN: 71410 AF XY: 0.0000287 show subpopulations
GnomAD4 exome AF: 0.0000363 AC: 46AN: 1267672Hom.: 0 Cov.: 53 AF XY: 0.0000278 AC XY: 17AN XY: 610788 show subpopulations
GnomAD4 genome AF: 0.000433 AC: 66AN: 152362Hom.: 0 Cov.: 34 AF XY: 0.000403 AC XY: 30AN XY: 74496 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1550C>T (p.A517V) alteration is located in exon 1 (coding exon 1) of the PSAPL1 gene. This alteration results from a C to T substitution at nucleotide position 1550, causing the alanine (A) at amino acid position 517 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at